Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT05954117
What this trial is testing

Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia

Who this might be right for
Esophageal Adenocarcinoma
University Hospital, Clermont-Ferrand 60
Testing effectiveness (Phase 2)UnknownNCT03789617
What this trial is testing

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Who this might be right for
EBV Associated Extranodal NK/T-cell LymphomaEBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
Eutilex 72
Large-scale testing (Phase 3)Looking for participantsNCT05188313
What this trial is testing

TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer

Who this might be right for
Esophageal CancerEsophageal Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 376
Large-scale testing (Phase 3)Study completedNCT03933449
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 123
Large-scale testing (Phase 3)UnknownNCT02773524
What this trial is testing

Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Who this might be right for
Gastro-Oesophageal Cancer
Australasian Gastro-Intestinal Trials Group 250
Not applicableStudy completedNCT01882478
What this trial is testing

Cryotherapy -BEATS-RF Ablation Trial

Who this might be right for
Barrett's Esophagus With Persistent Dysplasia orEarly Esophageal Adenocarcinoma Post Radio Frequency Ablation
Mayo Clinic 15
Early research (Phase 1)Ended earlyNCT04171141
What this trial is testing

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Who this might be right for
Gastrointestinal TumorsColorectal AdenocarcinomasGastric Adenocarcinomas+1 more
Pfizer 79
Not applicableLooking for participantsNCT05965999
What this trial is testing

Lucid Registry Study

Who this might be right for
Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With Dysplasia+1 more
Lucid Diagnostics, Inc. 8,000
Very early researchLooking for participantsNCT06824363
What this trial is testing

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Who this might be right for
Solid Tumor, AdultMalignant Solid TumorStomach Adenocarcinoma+1 more
University of California, Irvine 34
Testing effectiveness (Phase 2)Study completedNCT00354679
What this trial is testing

Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 34
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Early research (Phase 1)WithdrawnNCT02598687
What this trial is testing

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Maastricht Radiation Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT04018872
What this trial is testing

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Who this might be right for
Esophagus AdenocarcinomaEsophagus Squamous Cell CarcinomaGastroesophageal Junction Adenocarcinoma
Dallas VA Medical Center 78
Large-scale testing (Phase 3)Study completedNCT00047112
What this trial is testing

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 195
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507968
What this trial is testing

TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 101
Testing effectiveness (Phase 2)UnknownNCT03288350
What this trial is testing

MDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 55
Not applicableStudy completedNCT01582906
What this trial is testing

A Survivorship Care Plan for Gynaecological Cancer Patients

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 150
Not applicableStudy completedNCT02385604
What this trial is testing

The Predictive Value of CT-PET in Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
St. James's Hospital, Ireland 250
Not applicableStudy completedNCT03528629
What this trial is testing

IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric CancerGastro-esophageal Junction (GEJ) Cancer
Astellas Pharma Inc 18
Next Page